Lung Cancer Trials Ask AI to find trials
UnknownNot applicableNCT02783079
Official study title

Insomnia Interventions in Cancer Survivors

Study summary

This study looks at two different interventions used for the treatment of insomnia in survivors of breast, colon, lung, prostate and gynecologic cancer.

Ask AI to explain this study
Start here

Key things to know

Main goalTreatment

This describes the study’s primary purpose.

What is being studiedCBT and MBSR

The study team can explain what participation involves.

Who it may be forInsomnia

These are broad labels—not an eligibility decision.

Checked against the public recordLast updated May 26, 2016 · Source: ClinicalTrials.gov

Is enrollment open?Unknown

Ask the study team to confirm whether enrollment is open.

What kind of study?Not applicable

Interventional

Where is it offered?2 U.S. locations

Locations may change over time.

Who runs it?The Cooper Health System

Study sponsor

01
Study overview

What this study is about

Purpose
Treatment
Study type
Interventional
Phase
Not applicable
Sponsor
The Cooper Health System
Interventions being studied
Behavioral: CBT; Behavioral: MBSR
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

Treatment approach
Supportive or behavioral care→
03
Public criteria

Who may be able to participate

The sponsor separates these requirements into two groups. You do not need to interpret them alone—use them to guide a conversation with the study team.

Requirements people may need to meetInclusion criteria
  • signed informed consent
  • age 18 and over
  • diagnosis of breast, colon, lung, prostate or gynecologic cancer that is non metastatic
  • receiving treatment at one of the outpatient offices of the MD Anderson Cancer Center at Cooper
  • Self reported insomnia
  • Not currently taking any medications to treat insomnia
  • No medical or psychological condition that would prevent successful protocol completion in the opinion of investigator.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • MD Anderson Cancer Center at CooperCamden, New Jersey
  • MD Anderson Cancer Center at CooperVoorhees Township, New Jersey

Source and freshness
Processed from ClinicalTrials.gov. Last public update: May 26, 2016. Always confirm current availability with the study team.

View original record ↗